162 related articles for article (PubMed ID: 11562959)
41. Novel bicyclic furanopyrimidines with dual anti-VZV and -HCMV activity.
McGuigan C; Brancale A; Andrei G; Snoeck R; De Clercq E; Balzarini J
Bioorg Med Chem Lett; 2003 Dec; 13(24):4511-3. PubMed ID: 14643358
[TBL] [Abstract][Full Text] [Related]
42. The unabated synthesis of new nucleoside analogues with antiviral potential: a tribute to Morris J. Robins.
De Clercq E
Nucleosides Nucleotides Nucleic Acids; 2009 May; 28(5):586-600. PubMed ID: 20183603
[TBL] [Abstract][Full Text] [Related]
43. Synthesis and evaluation of multisubstrate bicyclic pyrimidine nucleoside inhibitors of human thymidine phosphorylase.
Allan AL; Gladstone PL; Price ML; Hopkins SA; Juarez JC; Doñate F; Ternansky RJ; Shaw DE; Ganem B; Li Y; Wang W; Ealick S
J Med Chem; 2006 Dec; 49(26):7807-15. PubMed ID: 17181163
[TBL] [Abstract][Full Text] [Related]
44. 5-(1-Substituted) alkyl pyrimidine nucleosides as antiviral (herpes) agents.
Kumar R
Curr Med Chem; 2004 Oct; 11(20):2749-66. PubMed ID: 15544474
[TBL] [Abstract][Full Text] [Related]
45. Bicyclic nucleoside inhibitors of varicella-zoster virus: synthesis and biological evaluation of 2',3'-dideoxy-3'-fluoro and 2'-deoxy-xylo derivatives.
Carangio A; McGuigan C; Andrei G; Snoeck R; De Clercq E; Balzarini J
Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):935-7. PubMed ID: 14565315
[No Abstract] [Full Text] [Related]
46. Synthesis and antiviral activity of (Z)- and (E)-2,2-[bis(hydroxymethyl)cyclopropylidene]methylpurines and -pyrimidines: second-generation methylenecyclopropane analogues of nucleosides.
Zhou S; Breitenbach JM; Borysko KZ; Drach JC; Kern ER; Gullen E; Cheng YC; Zemlicka J
J Med Chem; 2004 Jan; 47(3):566-75. PubMed ID: 14736238
[TBL] [Abstract][Full Text] [Related]
47. Bicyclic nucleoside inhibitors of Varicella-Zoster Virus (VZV): the effect of a terminal halogen substitution in the side-chain.
Brancale A; McGuigan C; Andrei G; Snoeck R; De Clercq E; Balzarini J
Bioorg Med Chem Lett; 2000 Jun; 10(11):1215-7. PubMed ID: 10866384
[TBL] [Abstract][Full Text] [Related]
48. Structure-activity relationships of (E)-5-(2-bromovinyl)uracil and related pyrimidine nucleosides as antiviral agents for herpes viruses.
Choi Y; Li L; Grill S; Gullen E; Lee CS; Gumina G; Tsujii E; Cheng YC; Chu CK
J Med Chem; 2000 Jun; 43(13):2538-46. PubMed ID: 10891113
[TBL] [Abstract][Full Text] [Related]
49. New conformationally locked bicyclic N,O-nucleoside analogues of antiviral drugs.
Procopio A; Alcaro S; De Nino A; Maiuolo L; Ortuso F; Sindona G
Bioorg Med Chem Lett; 2005 Feb; 15(3):545-50. PubMed ID: 15664810
[TBL] [Abstract][Full Text] [Related]
50. FV100 as a new approach for the possible treatment of varicella-zoster virus infection.
McGuigan C; Balzarini J
J Antimicrob Chemother; 2009 Oct; 64(4):671-3. PubMed ID: 19679595
[TBL] [Abstract][Full Text] [Related]
51. Susceptibilities of several clinical varicella-zoster virus (VZV) isolates and drug-resistant VZV strains to bicyclic furano pyrimidine nucleosides.
Andrei G; Sienaert R; McGuigan C; De Clercq E; Balzarini J; Snoeck R
Antimicrob Agents Chemother; 2005 Mar; 49(3):1081-6. PubMed ID: 15728906
[TBL] [Abstract][Full Text] [Related]
52. Synthesis and anti-herpes virus activity of 2'-deoxy-4'-thiopyrimidine nucleosides.
Rahim SG; Trivedi N; Bogunovic-Batchelor MV; Hardy GW; Mills G; Selway JW; Snowden W; Littler E; Coe PL; Basnak I; Whale RF; Walker RT
J Med Chem; 1996 Feb; 39(3):789-95. PubMed ID: 8576922
[TBL] [Abstract][Full Text] [Related]
53. FV-100: the most potent and selective anti-varicella zoster virus agent reported to date.
Migliore M
Antivir Chem Chemother; 2010 Jan; 20(3):107-15. PubMed ID: 20054098
[TBL] [Abstract][Full Text] [Related]
54. Alkyloxyphenyl furano pyrimidines as potent and selective anti-VZV agents with enhanced water solubility.
McGuigan C; Blewett S; Siccardi D; Erichsen JT; Andrei G; Snoek R; De Clercq E; Balzarini J
Antivir Chem Chemother; 2002 Mar; 13(2):91-9. PubMed ID: 12238533
[TBL] [Abstract][Full Text] [Related]
55. Synthesis and antiviral properties of 5-vinylpyrimidine nucleoside analogs.
De Clercq E; Walker RT
Pharmacol Ther; 1984; 26(1):1-44. PubMed ID: 6099893
[TBL] [Abstract][Full Text] [Related]
56. Advances and Perspectives in the Management of Varicella-Zoster Virus Infections.
Andrei G; Snoeck R
Molecules; 2021 Feb; 26(4):. PubMed ID: 33672709
[TBL] [Abstract][Full Text] [Related]
57. Total synthesis of N-malayamycin A and related bicyclic purine and pyrimidine nucleosides.
Hanessian S; Huang G; Chenel C; Machaalani R; Loiseleur O
J Org Chem; 2005 Aug; 70(17):6721-34. PubMed ID: 16095292
[TBL] [Abstract][Full Text] [Related]
58. Inactivity of the bicyclic pyrimidine nucleoside analogues against simian varicella virus (SVV) does not correlate with their substrate activity for SVV-encoded thymidine kinase.
Sienaert R; Andrei G; Snoeck R; De Clercq E; McGuigan C; Balzarini J
Biochem Biophys Res Commun; 2004 Mar; 315(4):877-83. PubMed ID: 14985094
[TBL] [Abstract][Full Text] [Related]
59. Synthesis of 3'-C-hydroxymethyl-substituted pyrimidine and purine nucleosides as potential anti-hepatitis C virus (HCV) agents.
Pei X; Choi WJ; Kim YM; Zhao LX; Jeong LS
Arch Pharm Res; 2008 Jul; 31(7):843-9. PubMed ID: 18704325
[TBL] [Abstract][Full Text] [Related]
60. 6-N-substituted derivatives of adenine arabinoside as selective inhibitors of varicella-zoster virus.
Koszalka GW; Averett DR; Fyfe JA; Roberts GB; Spector T; Biron K; Krenitsky TA
Antimicrob Agents Chemother; 1991 Jul; 35(7):1437-43. PubMed ID: 1656862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
